Resistin was first described as a factor contributing to the development of insulin resistance and diabetes mellitus in humans; a debate is still ongoing regarding its exact role in obesity, in insulin sensitivity, and in the development of type 2 diabetes mellitus (DM2) [44]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.